Stock Comparison

JNJ vs PFE

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricJNJJohnson & JohnsonPFEPfizer Inc.
Market Cap$514.75B$143B
Current Price$213.65$25.15
P/E Ratio36.9017.84
Revenue Growth 1Y4.3%6.8%
Net Margin15.8%12.6%
ROE20.1%9%
ROIC20.6%7.9%
Debt/Equity0.530.76
FCF Yield3.9%6.9%
Dividend Yield2.3%6.6%
Loading chart...

JNJ vs PFE: Key Questions Answered

Which is the cheapest stock: JNJ or PFE?

Based on P/E ratio, Pfizer Inc. (PFE) is the cheapest at 17.8x earnings. Johnson & Johnson (JNJ) is the most expensive at 36.9x. A lower P/E can indicate better value, but always consider growth rates too.

Which stock is growing the fastest: JNJ or PFE?

Pfizer Inc. (PFE) is growing the fastest with 6.8% revenue growth. Johnson & Johnson has the slowest growth at 4.3%. Higher growth often justifies higher valuations.

Which has the best profit margins: JNJ or PFE?

Johnson & Johnson (JNJ) has the strongest profitability with a 15.8% net margin. Pfizer Inc. has the lowest at 12.6%. Higher margins indicate pricing power and efficiency.

Which pays the highest dividend: JNJ or PFE?

Pfizer Inc. (PFE) offers the highest dividend yield of 6.6%. Johnson & Johnson has the lowest at 2.3%. For income investors, higher yield matters, but check payout sustainability.

Which is the largest company: JNJ or PFE?

Johnson & Johnson (JNJ) is the largest company with a market cap of $514.7B. Pfizer Inc. is the smallest at $143.0B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: JNJ or PFE?

Johnson & Johnson (JNJ) generates the best returns on shareholder equity with an ROE of 20.1%. Pfizer Inc. has the lowest at 9.0%. Higher ROE indicates efficient use of capital.